EUVIMEDScopri EUVIMED
Video/Audio

Pan-cancer Bioinformatics Analysis Combined with Colon Cancer Experimental Validation: A Study on TMED3 as a Diagnostic and Prognostic Biomarker

Yueming Hu, Ting Liu, Li Tian, Jinheng Xu, Bohai Cao

Journal of Visualized Experiments · 2026

DOI: 10.3791/71848 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Yueming Hu and 4 co-authors. Institution: Department of Pathology, Tangshan Central Hospital; 56199643@qq.com. Major MEDLINE topics: Biomarkers, Tumor, Colonic Neoplasms, Computational Biology, Membrane Proteins.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Transmembrane Emp24 Protein Transport Domain 3 (TMED3), a member of the p24 protein family, has been implicated in tumor proliferation, invasion, and migration. This study aimed to evaluate the expression patterns, prognostic significance, immune associations, and potential biological functions of TMED3 across multiple cancer types using pan-cancer bioinformatics analysis combined with immunohistochemical (IHC) validation in colon cancer. Multiomics datasets from The Cancer Genome Atlas, Genotype-Tissue Expression, UALCAN, Human Protein Atlas, and cBioPortal databases were analyzed to investigate TMED3 expression and genetic alterations in pan-cancer. Immunohistochemistry was performed to evaluate TMED3 protein expression in colon cancer tissues. Kaplan-Meier survival analysis and Cox regression analysis were used to assess the prognostic value of TMED3. Spearman correlation analysis was conducted to evaluate the associations of TMED3 with tumor mutational burden, microsatellite instability (MSI), immune cell infiltration, and immune checkpoints. Gene Set Enrichment Analysis was performed to investigate potential biological pathways associated with TMED3 in colon cancer. TMED3 expression was elevated in most tumor types and was associated with unfavorable overall survival and disease-specific survival in adrenocortical carcinoma, colon adenocarcinoma, and uveal melanoma. The greatest frequency of TMED3 genetic alterations was identified in mesothelioma, with amplification representing the predominant alteration type. In addition, TMED3 expression showed significant correlations with tumor mutational burden and microsatellite instability in kidney renal clear cell carcinoma, stomach adenocarcinoma, and uterine corpus endometrial carcinoma. TMED3 expression was also associated with immune infiltration and immune checkpoint expression in several tumors. IHC analysis demonstrated increased TMED3 expression in colon cancer tissues compared with normal colon tissues and showed an association with T stage. Functional enrichment analysis identified pathways related to ribosome, antigen processing and presentation, oxidative phosphorylation, and pentose phosphate. These findings indicate that TMED3 may represent a promising biomarker for the diagnosis and prognostic evaluation of colon cancer as well as other tumor types.

Subjects

MeSH terms (MEDLINE)

Biomarkers, TumorColonic NeoplasmsComputational BiologyMembrane ProteinsHumansPrognosisImmunohistochemistryFemale

Substances

Biomarkers, TumorMembrane Proteins

Authors and institutions

  • Department of Pathology, Tangshan Central Hospital; 56199643@qq.com.
  • Department of Pathology, Beijing Ditan Hospital, Capital Medical University.
  • Department of Pathology, Tangshan Central Hospital.

Cite

APA

Hu, Y., Liu, T., Tian, L., Xu, J., & Cao, B. (2026). Pan-cancer Bioinformatics Analysis Combined with Colon Cancer Experimental Validation: A Study on TMED3 as a Diagnostic and Prognostic Biomarker. Journal of Visualized Experiments. https://doi.org/10.3791/71848

Vancouver

Hu Y, Liu T, Tian L, Xu J, Cao B. Pan-cancer Bioinformatics Analysis Combined with Colon Cancer Experimental Validation: A Study on TMED3 as a Diagnostic and Prognostic Biomarker. Journal of Visualized Experiments. 2026. doi:10.3791/71848

BibTeX
@article{Hu2026,
  author = {Hu, Yueming and Liu, Ting and Tian, Li and Xu, Jinheng and Cao, Bohai},
  title = {Pan-cancer Bioinformatics Analysis Combined with Colon Cancer Experimental Validation: A Study on TMED3 as a Diagnostic and Prognostic Biomarker},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/71848}
}
Start for free →